3 min read

Microbiology

Published the Updated

Several prokaryotic microbes (bacteria, archaea and their viruses) are known to cause diseases, but these microorganisms also provide invaluable models for exploring the mechanisms of living systems.
Biofilm de bactéries Pseudomonas aeruginosa formé dans un catheter central.

The department of Microbiology is studying the biological mechanisms governing the workings of bacteria, archaea and their viruses. Our research explores the function of prokaryotes and their viruses using mechanistic and integrative approaches. The department is structured around 16 research teams, three National Reference Centers and three collections, and focuses its research on five broad areas:

  • Prokaryotic evolution and genetic biodiversity
  • Cellular and molecular biology and microorganism physiology
  • Virulence and environmental adaptation
  • Microbiota role and dynamics
  • Antimicrobial resistance and novel therapeutic strategies
     

Are you a scientist? Learn more about ou department

Our key research in 2025

Exemple de plages de lyse d'un bactériophage infectant Escherichia coli
Exemple de plages de lyse d'un bactériophage infectant Escherichia coli Institut Pasteur/Nicolas Dufour, Laurent Debarbieux
Exemple de plages de lyse d'un bactériophage infectant Escherichia coli

Macrophages negatively impact phage therapy efficacy

Phage therapy is an antibacterial approach that can help patients infected with antibiotic-resistant bacteria. Research by the Department of Microbiology's Bacteriophage, Bacterium, Host team showed that alveolar macrophages limit the efficacy of this treatment by attacking bacteriophages.

Nature communications, 1 July 2025

Macrophages infectés avec Yersinia pestis.
Macrophages infectés avec Yersinia pestis. Institut Pasteur/Josué Barquero et Anne Derbise
Macrophages infectés avec Yersinia pestis.

Plague evolved to facilitate spread

This article shows that late in the three major plague pandemics the bacterial pathogen Yersinia pestis carried the same mutation that attenuated its virulence, allowing it to persist in rodent populations that were more isolated and fragmented than at the start of the pandemics.

Science, 29 May 2025

Read the press release
Coupe de tissu intestinal avec un marquage des cellules immunitaires
© Héloïse Rytter

Is your microbiota sensitive to food additives?

Why do certain food additives make some people sick but not others? The answer lies in your gut microbiota! This study developed a way of predicting the sensitivity of a given gut microbiota to certain food additives. This is a significant discovery that highlights the need to adapt our diet and paves the way for personalized nutrition!

Gut, 27 January 2025

Read the press release

Our previous key research

In 2024

Discovery of a family of bacterial defense systems

A defense system was discovered in Escherichia coli bacteria by a PhD student and his supervisor Isabelle Rosinski-Chupin. In this system, the bacteria eliminate a DNA molecule carrying an antibiotic resistance gene, or plasmid, but not before the resistance gene has been integrated into the bacterial chromosome. In defending themselves, the bacteria establish antibiotic resistance. This discovery is a step towards improving understanding of the spread of antibiotic resistance, a major public health challenge.

Nature communications, 15 May 2024

 

Viral RNA neutralizes bacterial defenses

Phages are viruses infecting bacteria that defend themselves with immune systems such as PARIS. This system prevents the phage from producing its proteins by destroying a bacterial transfer RNA. But some phages outmaneuver this defense by producing a modified version of the RNA, enabling them to establish infection anyway.

Nature, 7 August 2024

 

In 2023 

Off-target effects of Cas9 on bacterial gene expression

Powerful genetic manipulation tools derived from the CRISPR-Cas9 system can be used to modify gene expression. Gene specificity represents a key challenge, since so-called off-target effects can lead to non-specific effects, skewing the interpretation of experimental results. This study conducted on bacteria revealed an unexpected effect: Cas9 can block gene expression unpredictably by binding non-specifically upstream of genes.

Nucleic Acid Research, 24 April 2023

 

How the respiratory tract microbiome influences the severity of bacterial pneumonia

Scientists analyzed the inter-kingdom (bacteria, archaea, fungi, protozoa) diversity and composition of the respiratory tract microbiome (RTM) of patients with pneumonia due to Legionella pneumophila. After antibiotic treatment, the empty RTM niche is rapidly occupied by other bacteria. Thus, high biomass emerges as a biomarker for secondary/co-infections. The interplay of RTM equilibrium, pathogen load dynamics, and clinical interventions play a critical role in the recovery of pneumonia patients.

Cell Reports Medicine, 19 September 2023

 

A bridge for phospholipid traffic

Understanding how bacteria build and maintain their cell envelope is a major area of investigation in the fight against pathogens. However, current knowledge is mostly based on a handful of models. Using the diderm Firmicute V. parvula, scientists have identified a novel mechanism responsible for phospholipid trafficking that forms a trans-envelope bridge between the inner and outer membrane and is widely distributed in Gram-negative bacteria.

Nature Communications, 23 November 2023